Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 94

    1.

    Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

    De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, Nicolucci A.

    BMJ. 2009 Nov 6;339:b4531. doi: 10.1136/bmj.b4531. Review.PMID: 19897665 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Vitamin D compounds for people with chronic kidney disease not requiring dialysis.

    Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Oct 7;(4):CD008175.PMID: 19821446 [PubMed - in process]Related articles

    3.

    Vitamin D compounds for people with chronic kidney disease requiring dialysis.

    Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005633.PMID: 19821349 [PubMed - in process]Related articles

    4.

    Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

    Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF.

    Am J Kidney Dis. 2009 Oct;54(4):619-37. Epub 2009 Aug 18. Review.PMID: 19692157 [PubMed - indexed for MEDLINE]Related articles

    5.

    Aldosterone antagonists for preventing the progression of chronic kidney disease.

    Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007004. Review.PMID: 19588415 [PubMed - indexed for MEDLINE]Related articles

    6.

    HMG CoA reductase inhibitors (statins) for dialysis patients.

    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004289. Review.PMID: 19588351 [PubMed - indexed for MEDLINE]Related articles

    7.

    Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder.

    Navaneethan SD, Palmer SC, Schreiber MJ, Strippoli GF.

    Nephrology (Carlton). 2009 Jun;14(4):363-6. No abstract available. PMID: 19563376 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.

    Maione A, Strippoli GF.

    Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-86-9.PMID: 19484883 [PubMed - indexed for MEDLINE]Related articles

    9.

    HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

    Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007784. Review.PMID: 19370693 [PubMed - indexed for MEDLINE]Related articles

    10.

    HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

    Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Apr 15;(2):CD005019. Review.PMID: 19370615 [PubMed - indexed for MEDLINE]Related articles

    11.

    HMG CoA reductase inhibitors (statins) for dialysis patients.

    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004289. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004289. PMID: 19370598 [PubMed - indexed for MEDLINE]Related articles

    12.

    Sunset for statins after AURORA?

    Strippoli GF, Craig JC.

    N Engl J Med. 2009 Apr 2;360(14):1455-7. Epub 2009 Mar 30. No abstract available. PMID: 19332454 [PubMed - indexed for MEDLINE]Related articles

    13.

    Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

    Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF.

    Clin J Am Soc Nephrol. 2009 Mar;4(3):542-51. Epub 2009 Mar 4. Review.PMID: 19261819 [PubMed - indexed for MEDLINE]Related articles

    14.

    Taking aim at targets.

    Palmer SC, Craig JC, Strippoli GF.

    Nephrol Dial Transplant. 2009 May;24(5):1358-61. Epub 2009 Feb 11. No abstract available. PMID: 19211650 [PubMed - indexed for MEDLINE]Related articles

    15.

    IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice.

    Strippoli GF, Maione A, Schena FP, Tognoni G, Craig JC.

    Am J Kidney Dis. 2009 Jan;53(1):5-8. No abstract available. PMID: 19101396 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.

    Navaneethan SD, Viswanathan G, Strippoli GF.

    Drugs. 2008;68(15):2095-104. Review.PMID: 18840001 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Evidence-based guidelines and nephrological clinical practice: the GRADE system for rating of evidence]

    Bonifati C, Strippoli GF, Manno C, Schena FP.

    G Ital Nefrol. 2008 Jul-Aug;25(4):449-58. Review. Italian. PMID: 18663692 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.

    Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GF.

    Am J Kidney Dis. 2008 Sep;52(3):507-18. Epub 2008 Jul 9.PMID: 18617304 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

    Hodson EM, Craig JC, Strippoli GF, Webster AC.

    Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003774. Review.PMID: 18425894 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

    Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC.

    BMJ. 2008 Mar 22;336(7645):645-51. Epub 2008 Feb 25. Review. Erratum in: BMJ. 2009;339:b2951. PMID: 18299289 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    [Patient satisfaction in hemodialysis: a pilot cross-sectional analysis and a review]

    Pansini F, Gargano L, Sambati M, Dambrosio N, D'Altri C, Giannoccaro G, Boccia E, Cecilia A, Di Toro Mammarella R, Flammini A, Larosa S, Fici M, Sabella V, Falco M, Montalto G, Rindone F, Murgo AM, Greco V, Giannetto M, D'Agostino F, Pellegrini F, Invernizzi C, Strippoli GF, Manno C.

    G Ital Nefrol. 2007 Nov-Dec;24(6):584-94. Italian. PMID: 18278762 [PubMed - indexed for MEDLINE]Related articles

    22.

    Treatment for peritoneal dialysis-associated peritonitis.

    Wiggins KJ, Craig JC, Johnson DW, Strippoli GF.

    Cochrane Database Syst Rev. 2008 Jan 23;(1):CD005284. Review.PMID: 18254075 [PubMed - indexed for MEDLINE]Related articles

    23.

    Interventions for minimal change disease in adults with nephrotic syndrome.

    Palmer SC, Nand K, Strippoli GF.

    Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001537. Review.PMID: 18253993 [PubMed - indexed for MEDLINE]Related articles

    24.

    Meta-analysis of mycophenolate mofetil in IgA nephropathy.

    Navaneethan SD, Viswanathan G, Strippoli GF.

    Nephrology (Carlton). 2008 Feb;13(1):90. No abstract available. PMID: 18199113 [PubMed - indexed for MEDLINE]Related articles

    25.

    Current structure and organization for renal patient assistance in Italy.

    Alloatti S, Strippoli GF, Buccianti G, Daidone G, Schena FP; Italian Society of Nephrology.

    Nephrol Dial Transplant. 2008 Apr;23(4):1323-9. Epub 2008 Jan 8.PMID: 18182403 [PubMed - indexed for MEDLINE]Related articles

    26.

    Meta-analysis: vitamin D compounds in chronic kidney disease.

    Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF.

    Ann Intern Med. 2007 Dec 18;147(12):840-53.PMID: 18087055 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial.

    Maione A, Nicolucci A, Craig JC, Tognoni G, Moschetta A, Palasciano G, Pugliese G, Procaccini DA, Gesualdo L, Pellegrini F, Strippoli GF; LIRICO study group.

    J Nephrol. 2007 Nov-Dec;20(6):646-55.PMID: 18046666 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials.

    Wiggins KJ, Johnson DW, Craig JC, Strippoli GF.

    Am J Kidney Dis. 2007 Dec;50(6):967-88. Review. Erratum in: Am J Kidney Dis. 2009 Sep;54(3):585. PMID: 18037098 [PubMed - indexed for MEDLINE]Related articles

    29.

    A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate.

    Walker RG, Strippoli GF.

    Lancet. 2007 Oct 20;370(9596):1395-6. No abstract available. PMID: 17950848 [PubMed - indexed for MEDLINE]Related articles

    30.

    Choice of extracorporeal dialysis modality: can it be evidence based?

    Navaneethan SD, Viswanathan G, Strippoli GF.

    Minerva Urol Nefrol. 2007 Sep;59(3):261-7. Review.PMID: 17912223 [PubMed - indexed for MEDLINE]Related articles

    31.

    Sevelamer: a promising but unproven drug.

    Palmer SC, Craig JC, Strippoli GF.

    Nephrol Dial Transplant. 2007 Oct;22(10):2742-5. No abstract available. PMID: 17906325 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    [Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO).]

    Maione A, Nicolucci A, Craig JC, Tognoni G, Moschetta A, Palasciano G, Pugliese G, Procaccini DA, Gesualdo L, Pellegrini F, Strippoli GF.

    G Ital Nefrol. 2007 Sep-Oct;24(5):446-56. Italian. PMID: 17886213 [PubMed - in process]Related articles

    33.

    Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study.

    Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MC, Strippoli GF, Belfiglio M, Tognoni G, Valentini M, Nicolucci A; IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group.

    Clin J Am Soc Nephrol. 2007 Sep;2(5):984-91. Epub 2007 Aug 5.PMID: 17702724 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Interventions for preventing bone disease in kidney transplant recipients.

    Palmer SC, McGregor DO, Strippoli GF.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005015. Review.PMID: 17636784 [PubMed - indexed for MEDLINE]Related articles

    35.

    A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.

    Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.

    Am J Kidney Dis. 2007 Jun;49(6):763-75.PMID: 17533019 [PubMed - indexed for MEDLINE]Related articles

    36.

    Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients.

    Hodson EM, Jones CA, Strippoli GF, Webster AC, Craig JC.

    Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005129. Review.PMID: 17443573 [PubMed - indexed for MEDLINE]Related articles

    37.

    [Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology.]

    Cornella C, Torazza MC, Strippoli GF, Segoloni G.

    G Ital Nefrol. 2007 January-February;24(Suppl. 37):149-164. Italian. PMID: 17347963 [PubMed - as supplied by publisher]Related articles

    38.

    [Calcimimetics, phosphate binders, vitamin D and its analogues for treating secondary hyperparathyroidism in chronic kidney disease: guideline from the Italian Society of Nephrology.]

    Mazzaferro S, Cozzolino M, Marangella M, Strippoli GF, Messa P.

    G Ital Nefrol. 2007 Jan-Feb;24 Suppl 37:107-24. Italian. PMID: 17347960 [PubMed - in process]Related articles

    39.

    [Haemoglobin targets for chronic kidney disease: guideline from the Italian Society of Nephrology.]

    Canavese C, Strippoli GF, Bonomini M, Triolo G.

    G Ital Nefrol. 2007 Jan-Feb;24 Suppl 37:99-106. Italian. PMID: 17347959 [PubMed - in process]Related articles

    40.

    [Use of statins for preventing cardiovascular and renal outcomes in patients with chronic kidney disease excluding dialysis: guideline from the Italian Society of Nephrology.]

    De Nicola L, Strippoli GF, Ravani P, Del Vecchio L, Cianciaruso B.

    G Ital Nefrol. 2007 Jan-Feb;24 Suppl 37:83-90. Italian. PMID: 17347957 [PubMed - in process]Related articles

    41.

    [Treating lupus nephritis: guideline from the Italian Society of Nephrology.]

    Stratta P, Canavese C, Lupo A, Pozzi C, Passerini P, Cagnoli L, Manno C, Strippoli GF.

    G Ital Nefrol. 2007 Jan-Feb;24 Suppl 37:50-63. Italian. PMID: 17347955 [PubMed - in process]Related articles

    42.

    [Immunosuppressive and non-immunosuppressive agents for patients with IgA nephropathy: guideline from the Italian Society of Nephrology.]

    Pozzi C, Manno C, Passerini P, Strippoli GF, Lupo A, Stratta P, Cagnoli L.

    G Ital Nefrol. 2007 Jan-Feb;24 Suppl 37:30-49. Italian. PMID: 17347954 [PubMed - in process]Related articles

    43.

    [Therapeutic strategies for membranous nephropathy: guideline from the Italian Society of Nephrology.]

    Passerini P, Lupo A, Pozzi C, Manno C, Strippoli GF, Cagnoli L, Stratta P.

    G Ital Nefrol. 2007 Jan-Feb;24 Suppl 37:13-29. Italian. PMID: 17347953 [PubMed - in process]Related articles

    44.

    Haemoglobin targets: we were wrong, time to move on.

    Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC.

    Lancet. 2007 Feb 3;369(9559):346-50. No abstract available. PMID: 17276756 [PubMed - indexed for MEDLINE]Related articles

    45.

    Evidence for optimal hemoglobin targets in chronic kidney disease.

    Navaneethan SD, Bonifati C, Schena FP, Strippoli GF.

    J Nephrol. 2006 Sep-Oct;19(5):640-7. Review.PMID: 17136694 [PubMed - indexed for MEDLINE]Related articles

    46.

    Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.

    Rabindranath KS, Strippoli GF, Daly C, Roderick PJ, Wallace S, MacLeod AM.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006258. Review.PMID: 17054289 [PubMed - indexed for MEDLINE]Related articles

    47.

    Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

    Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006257. Review.PMID: 17054288 [PubMed - indexed for MEDLINE]Related articles

    48.

    Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.

    Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006254. Review.PMID: 17054287 [PubMed - indexed for MEDLINE]Related articles

    49.

    Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.

    Strippoli GF, Navaneethan SD, Craig JC.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003967. Review.PMID: 17054191 [PubMed - indexed for MEDLINE]Related articles

    50.

    Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection.

    Navaneethan SD, Querques M, Bonifati C, Strippoli GF.

    Diabetes Educ. 2006 Jul-Aug;32(4):596-602.PMID: 16873597 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...